Congruently, the loss of KAT6A results in a shift in the expression of HOX genes (body segment identity), and the reduction in the expression of DLX genes (jaw and palate development) and TBX genes (heart development), among other affected genes (Voss et al, 2009, 2012
Patients treated with Januvia exhibited a significant mean decrease from baseline in body weight compared to a significant weight gain in patients administered glipizide (-1.5 kg vs +1.1 kg)
blood pressure remains controlled Medication Tolerability: Occasional early satiety reported, but no severe adverse events One-Year Visit Weight: Down 9 kg overall (BMI 31 kg/m), approaching his target of losing 1012 kg HbA1c: 6.9%, well within the personalized target range set by his endocrinologist Lifestyle: Continues brisk walking 34 times weekly and has enrolled in a weight management support group Quality of Life: Richard reports feeling more energetic, with fewer episodes of low blood sugar after the sulfonylurea dose adjustment Discussion and Alignment with Research Findings Long-Term Projection: Based on modeling data similar to the CORE diabetes model, semaglutide may offer substantial long-term benefits, including reduced risk of cardiovascular complications and improved survival (17)(18)
EXTRA LIVER SUPPORT Weve also included L-cysteinein this formula
